20^th European Gastroenterology and Therapeutics Congress

Gastrointestinal Oncology: From Screening to Targeted Therapies

Gastrointestinal (GI) cancers—including colorectal, gastric, esophageal, liver, and pancreatic cancers—are among the leading causes of cancer-related mortality worldwide. This session provides a comprehensive overview of current trends in GI oncology, from early detection to advanced therapeutic strategies. Emphasis will be placed on the importance of screening programs, such as fecal immunochemical tests (FIT) and colonoscopy, in detecting precancerous lesions and early-stage colorectal cancer. Advances in molecular biology and genomics have led to the development of targeted therapies and immunotherapies, transforming treatment landscapes for many GI malignancies. Participants will explore biomarker-driven approaches, personalized medicine, and the integration of next-generation sequencing in clinical practice. The session also addresses challenges in managing advanced-stage cancers, the role of neoadjuvant and adjuvant therapy, and palliative care strategies. Case discussions and expert panels will provide attendees with practical insights into multidisciplinary cancer care, improving outcomes for patients with GI malignancies.